1.
Is Home Blood Pressure Monitoring Useful in the Management of Patients With Resistant Hypertension?
by Muxfeldt, Elizabeth S
American journal of hypertension, 2015-02, Vol.28 (2), p.190-199
2.
Prognosis of White-Coat and Masked Hypertension International Database of Home Blood Pressure in Relation to Cardiovascular Outcome
by Stergiou, George S
Hypertension (Dallas, Tex. 1979), 2014-04, Vol.63 (4), p.675-682
3.
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.895-905
4.
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
by Chapman, Neil
Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845
5.
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients
by Pierdomenico, Sante D
American journal of hypertension, 2017-11-01, Vol.30 (11), p.1106-1111
6.
Ambulatory Blood Pressure Patterns in Children With Chronic Kidney Disease
by Samuels, Joshua
Hypertension (Dallas, Tex. 1979), 2012-07, Vol.60 (1), p.43-50
7.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
8.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang...
by Dahlöf, Björn
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.895-906
9.
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-...
by Poulter, Neil R
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.907-913
10.
Molecular Characterization of Reactive Oxygen Species in Systemic and Pulmonary Hypertension
by Zuo, Li
American journal of hypertension, 2014-05, Vol.27 (5), p.643-650
11.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
12.
Azilsartan Is Associated With Increased Circulating Angiotensin-(1–7) Levels and Reduced Renovascular 20-HETE Levels
by Carroll, Mairéad A
American journal of hypertension, 2015-05, Vol.28 (5), p.664-671
13.
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies
by Carr, Albert A
The American journal of cardiology, 2005, Vol.96 (11), p.1530-1536
14.
Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy)
by Chinali, Marcello, MD, PhD
The American journal of cardiology, 2009, Vol.104 (8), p.1098-1104
15.
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
by Lu, Jiapeng
The Lancet (British edition), 2017-12-09, Vol.390 (10112), p.2549-2558
16.
Gut Dysbiosis Is Linked to Hypertension
by Yang, Tao
Hypertension (Dallas, Tex. 1979), 2015-06, Vol.65 (6), p.1331-1340
17.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proo...
by Townsend, Raymond R
The Lancet (British edition), 2017-11-11, Vol.390 (10108), p.2160-2170
18.
Prevalence of Resistant Hypertension in the United States, 2003–2008
by Persell, Stephen D
Hypertension (Dallas, Tex. 1979), 2011-06, Vol.57 (6), p.1076-1080
19.
J-shaped relation between blood pressure and stroke in treated hypertensives
by Vokó, Zoltán
Hypertension (Dallas, Tex. 1979), 1999-01-01, Vol.34 (6), p.1181-1181
20.
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
by Olsen, Michael H, DMSc
The Lancet (British edition), 2016, Vol.388 (10060), p.2665-2712
